Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of hyaluronic acid and melatonin appears to be a therapeutic approach rather than a single marketed drug product. Research indicates this combination has potential applications in joint health, bone regeneration, and rheumatoid arthritis treatment. Hyaluronic acid (HA) plays a critical role in the lubricating and buffering properties of synovial fluid in joints, while melatonin is an endocrine hormone that can regulate bone and cartilage homeostasis[1]. Studies show that melatonin can enhance HA synthesis through the Sirt1 signaling pathway, protecting synovial membrane cells and interrupting cell senescence[1][7]. Recent research has explored encapsulating melatonin in hyalurosomes (HA-based vesicles) and loading them in collagen thermosensitive poloxamer 407 hydrogels for intra-articular administration in rheumatoid arthritis models[2][5]. This approach showed superior effects in improving joint healing, cartilage repair, and reducing inflammation compared to other formulations[2][5]. Additionally, the combination of melatonin and hyaluronic acid has shown promising results in maxillary sinus augmentation procedures, enhancing bone density without complications[3]. ## Formulation and Delivery Systems The combination has been formulated in several ways: 1. Melatonin-loaded hyaluronic acid and poly(vinyl alcohol) gels prepared using freeze-thaw techniques and emulsion methods[4] 2. Melatonin encapsulated in hyalurosomes (particle size ~71.5 nm) loaded in collagen thermosensitive poloxamer 407 hydrogels for intra-articular administration[2][5] 3. Direct application in maxillary sinus augmentation procedures[3] ## Therapeutic Applications The hyaluronic acid and melatonin combination has shown potential in: - Rheumatoid arthritis management via intra-articular administration[2][5] - Bone regeneration in dental procedures (maxillary sinus augmentation)[3] - Joint health maintenance and osteoarthritis prevention[1][7] ## Mechanism of Action The therapeutic effects appear to work through several mechanisms: - Melatonin activates the Sirt1 signaling pathway, which enhances hyaluronic acid synthesis and maintains HAS2 (hyaluronic acid synthase 2) expression[1][7] - The combination reduces inflammatory markers (TNF-α, IL1) and oxidative stress markers (MDA)[2][5] - It promotes activation of protective pathways (NRF2, HO-1)[2][5] - The synergistic effect of hyaluronic acid in hyalurosomes and collagen in hydrogels promotes joint healing[2][5] This combination represents an innovative approach to treating joint disorders and promoting bone regeneration with potentially fewer side effects than conventional treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyaluronic Acid and Melatonin Combination.